India biz may stabilise in FY19, but govt price caps a concern: Sun Pharma 0 02.10.2018 14:40 Business Standard The company's India business revenues stood at Rs 80.29 billion in 2017-18, a growth of 4 per cent over 2016-17 Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
